Skip to main content

Table 3 Patient medication

From: First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease

  Patient no. Pre-FUS l-dopa equivalents (mg/day) 3 months post-FUS l-dopa equivalents (mg/day) Pre-FUS dopamine agonists (mg/day) 3 months post-FUS dopamine agonists (mg/day)
Group 1 1 1,000 1,000 Ropinirol: 3 Ropinirol: 3
Amantadine: 300 Amantadine: 300
Biperiden: 4 Biperiden: 4
2 800 800 - -
3 300 - - -
4 600 600 Biperiden: 6 -
Group 2 5 1,000 - - -
6 1,000 - - -
7 1,200 600 Ropinirol: 2 Ropinirol: 2
8 - - - -
9 600 1,000 Rotigotine: 8 -
10 1,000 600 Ropinirol: 10 -
11 - - Amantadine: 1,000 Amantadine: 600
12 800 800 Ropinirol: 4 Ropinirol: 4
13 800 500 Amantadine: 300 Amantadine: 300
Entacapone: 1,600 Entacapone: 1,000
Mean   827 536   
  1. Pre- and postoperative antiparkinsonian medication. Patients 8 and 11 had stopped their l-dopa intake long before the intervention. Mean intakes of l-dopa equivalents were calculated over 11 patients.